AIV Logo AIV Assistant

 Logo Absci Corporation Common Stock - ABSI 2.81 USD

EPS
-0.93
P/B
2.12
ROE
-42.24
Beta
2.22
Target Price
8.00 USD

2.810 USD

2.810 USD

Daily: +1.81%
Key Metrics

EPS: -0.93

Book Value: 1.95

Price to Book: 2.12

Debt/Equity: 6.02

% Insiders: 20.326%

Growth

Revenue Growth: -0.62%

Estimates

Forward P/E: -5.82

Forward EPS: -0.71

Target Mean Price: 8.00

 Logo About Absci Corporation Common Stock - (ABSI)

Country: United States

Sector: Health Care

Website: nan

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Exchange Ticker
NMS (United States) ABSI

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion